Aims & Scope

The official journal of the Sociedad Española de Quimioterapia (Spanish Society of Chemotherapy), publishes articles that further knowledge and advance the science and application of antimicrobial chemotherapy with antibiotics and antifungal, antiviral and antiprotozoal agents primarily in human medicine.

Authors sign an exclusive license agreement, where authors have copyright but license exclusive rights in their article to the Publisher.

All manuscripts are free open access.

Revista Española de Quimioterapia includes the following sections: reviews, original articles, brierf reports, letters, and consensus documents.

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 2.2
2024 1.90

SJR (SCImago Journal Rank)

Year Value
2024 0.505

Quartile

Year Value
2024 Q3

h-index

Year Value
2024 35

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.


Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

  • Insights for COVID-19 in 2023

    Citation: 66

    Authors: Francisco Javier, Manuel, José María, Santiago, Fernando, Julián, Rafael, Pilar, Alejandra, Alberto, Teresa, Javier, Juan, Mari Cruz, Emilio

  • New variants of SARS-CoV-2

    Citation: 51

    Authors: Rafael, Pilar, Alejandra, Alberto, Javier, Juan, Teresa, Mari Cruz, Francisco Javier, Manuel, José María, Santiago, Fernando, Julián, Emilio


Quick Facts

Current Factor
2.2
First Published: 2025

SJR (SCImago Journal Rank)

SJR
0.505
First Published: 2024

Quartile

Current Quartile
Q3
First Published: 2024

Similar Journals

Top Journals in Related Fields